Delpor
News View All Delpor is a clinical-stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic diseases. The Company is focusing on CNS conditions including Schizophrenia, Opioid Use Disorder, Spasticity, Parkinson’s, Alzheimer’s, and MS.
Private Company
Total funding raised: $10M
About
News View All Delpor is a clinical-stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic diseases. The Company is focusing on CNS conditions including Schizophrenia, Opioid Use Disorder, Spasticity, Parkinson’s, Alzheimer’s, and MS.
BiologicsDrug DeliverySmall Molecules
Funding History
1Total raised:$10M
Series A$10M